We invite you to join the latest “Ask the Expert” session with Kathy Hayward, Respiratory Educator at Calgary COPD & Asthma Program, as she provides tips for how to best manage COPD, the importance of mucus clearance and inhaled medications, and the impact COVID-19 may have on COPD.
The personalised approach to inhaled medicine - Ensure your respiratory patients are prepared in case of emergency
Join Professor Anna Murphy as she highlights the role of spacers in optimising inhaled medication delivery for people of all ages and ensuring patients are prepared in case of emergency.
Bronchiectasis – How Key is the Role of Airway Clearance? A Practical Review and Guide for this Pandemic and Beyond
Join Professor James Chalmers, Pamela Vaughn and Paul McCallion as they discuss the importance of airway clearance therapy in Bronchiectasis patients, global guidelines and recommendations during the pandemic.
Webinar Will Also Cover:
Bronchiectasis disease area
Airway clearance therapy
Special care during the pandemic
Global recommendations and practices to manage bronchiectasis
Effective management of your COPD patients in COVID times - How to help keep them out of the hospital
We invite you to join in on the conversation with Dr. Alan Kaplan as he discusses COVID-19 risk for COPD patients, pharmacological and non-pharmacological COPD treatments, and tips for conducting virtual COPD visits.
Management of your respiratory condition such as asthma or COPD is more important than ever. As such, we would like to invite you to join Dr. Douglas Mack and Dr. Mariam Hanna as they discuss:
How to best manage your and/or your child’s asthma
How to achieve good asthma control
What to do in an asthma emergency
Tips and tricks for administering inhaler medication to children
Join Dr. Omar Usmani as he discusses the importance of proper inhaler technique and technique check-ups, as well as inhaler management during COVID-19 and the role that spacers play in asthma control.
Join Dr. Douglas Mack and Dr. Mariam Hanna as they discuss the importance of asthma control in today’s world, as well as the shift to virtual appointments including tools and tips to optimize virtual asthma assessments. Please see a recording of the session below.
The webinar will cover:
Asthma measures for Back to School amid COVID-19
The reality of asthma in Canada – misperception about asthma
When to conduct virtual vs face-to-face appointments
Join Isabelle LeClerc in this 30-minute webinar as she discusses the importance of airway clearance techniques and oscillating positive expiratory pressure (OPEP) devices, including during the COVID-19 pandemic. Please see a recording of the session below.
In Overcoming Barriers to Physical Activity & Online Interventions, Lauren Tracey discusses the importance of understanding barriers and what you, as an exercise professional, can do to best help your clients. Please see a recording of the session below.
In the Preparing for a Telemedicine Session webinar, Dr. Josianne Hamel-Bourbeau discussed the intricacies of telemedicine, and how to deliver the best care for your patients while remaining as efficient as possible. Please see a recording of the session below.
Expert insights from UK respiratory specialists and school nurses on fall and winter asthma triggers and advancements in asthma care and innovative technologies supporting better management among children and adolescents.
Today Trudell Medical International announces it is extending its global footprint with its expansion into the Australian market with the establishment of Trudell Medical Australia Propriety Limited (Trudell Medical Australia).
Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika®OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions
As current MDIs contain hydrofluorocarbon propellants, it would be beneficial to find ways to reduce carbon emissions without compromising patient safety.
This lab study investigated a way to optimize the modelled lung dose per actuation while at the same time minimizing the carbon emissions from the MDI
